AI Tokens
Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

Analysis of Liquidity Ratios
Quarterly Data

Microsoft Excel

Liquidity Ratios (Summary)

UnitedHealth Group Inc., liquidity ratios (quarterly data)

Microsoft Excel
Sep 30, 2026 Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Current ratio 0.74 0.78 0.80 0.79 0.82 0.85 0.85 0.83 0.91 0.88 0.85 0.79 0.80 0.80 0.81 0.77 0.82 0.77 0.78
Quick ratio 0.66 0.70 0.72 0.70 0.74 0.76 0.77 0.75 0.83 0.81 0.79 0.73 0.75 0.74 0.75 0.70 0.77 0.71 0.72
Cash ratio 0.25 0.28 0.27 0.24 0.26 0.29 0.30 0.28 0.37 0.33 0.35 0.34 0.42 0.44 0.43 0.36 0.46 0.36 0.37

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The liquidity profile of the organization is characterized by a consistent state where current liabilities exceed current assets, as indicated by ratios remaining below 1.00 throughout the reported period. A general trend of volatility is observed, with a period of improvement peaking in late 2024, followed by a sustained decline through the third quarter of 2026.

Current Ratio Analysis
The current ratio fluctuated between 0.77 and 0.82 during 2022 and 2023. A positive trend emerged in 2024, reaching a peak of 0.91 by September 30, 2024. However, this peak was followed by a gradual contraction, with the ratio descending to 0.74 by September 30, 2026, marking the lowest point in the analyzed timeframe.
Quick Ratio Analysis
The quick ratio closely mirrors the movements of the current ratio, suggesting that inventory or other less liquid current assets represent a minimal portion of the total current asset base. The ratio reached its maximum value of 0.83 in September 2024 before entering a downward trajectory that concluded at 0.66 in September 2026.
Cash Ratio Analysis
The cash ratio exhibited the most significant variance, peaking at 0.46 in September 2022. After a period of relative stability, a notable downward shift occurred starting in late 2023. The ratio reached a low of 0.24 by December 31, 2025, and ended the period at 0.25, indicating a reduction in the immediate cash buffer available to cover short-term obligations.
Overall Liquidity Trajectory
A correlated decline is observed across all three liquidity metrics starting from the first quarter of 2025. The synchronization of the decrease in the current, quick, and cash ratios suggests a systemic reduction in liquidity or an increase in short-term liabilities that outpaced the growth of liquid assets during the final two years of the period.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Current Ratio

UnitedHealth Group Inc., current ratio calculation (quarterly data)

Microsoft Excel
Sep 30, 2026 Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Current assets 85,595 86,860 91,127 90,582 95,067 93,699 96,285 85,779 92,258 92,038 88,942 78,437 91,905 89,869 93,895 69,069 82,937 68,356 69,029
Current liabilities 115,835 111,820 114,124 114,897 115,526 110,781 113,471 103,769 101,565 104,670 104,431 99,054 114,179 112,981 116,482 89,237 100,935 88,698 88,170
Liquidity Ratio
Current ratio1 0.74 0.78 0.80 0.79 0.82 0.85 0.85 0.83 0.91 0.88 0.85 0.79 0.80 0.80 0.81 0.77 0.82 0.77 0.78
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories 1.45 1.38 1.39 1.58 1.70 1.82 1.78 1.67 1.60 1.68 1.60 1.64 1.74 1.64 1.68 1.63 1.86 2.01 1.85
Elevance Health Inc. 1.47 1.52 1.48 1.54 1.56 1.44 1.43 1.45 1.50 1.49 1.37 1.44 1.41 1.44 1.43 1.40 1.35 1.36 1.36
Intuitive Surgical Inc. 3.33 4.96 4.61 4.87 4.73 5.17 4.98 4.07 4.30 5.15 5.55 4.76 5.31 5.22 5.26 4.40 5.10 5.36 5.22
Medtronic PLC 2.54 2.42 2.01 1.85 1.90 1.84 2.13 2.03 2.30 2.29 2.42 2.39 1.76 1.76 1.58 1.86 2.61 2.91 2.89

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q3 2026 Calculation
Current ratio = Current assets ÷ Current liabilities
= 85,595 ÷ 115,835 = 0.74

2 Click competitor name to see calculations.


The liquidity profile of the organization is characterized by a current ratio that consistently remains below 1.00 throughout the analyzed period, indicating that current liabilities exceed current assets. This sustained position suggests a strategic reliance on operational cash flows or short-term financing to meet immediate obligations rather than maintaining a high buffer of liquid assets.

Current Assets Trends
Current assets exhibited significant volatility, fluctuating between a low of 68,356 million USD in June 2022 and a peak of 96,285 million USD in March 2025. A general upward trajectory was observed from 2022 through early 2025, followed by a slight contraction toward 85,595 million USD by September 2026.
Current Liabilities Trends
Current liabilities demonstrated a parallel volatility, ranging from 88,170 million USD in March 2022 to a peak of 116,482 million USD in March 2023. While liabilities saw a temporary reduction toward the end of 2023, they trended upward again through 2025 and 2026, concluding at 115,835 million USD.
Current Ratio Dynamics
The current ratio showed a gradual improvement phase beginning in late 2022, rising from 0.77 to a period peak of 0.91 in September 2024. This peak represented the organization's strongest short-term liquidity position in the reported timeframe. However, this trend reversed after September 2024, with the ratio declining steadily to 0.74 by September 2026, marking the lowest liquidity level across the entire sequence.

The convergence of increasing current liabilities and stagnating current assets in the final quarters of the period resulted in the observed deterioration of the current ratio. The consistent gap between assets and liabilities suggests a structural approach to working capital management where liquidity is optimized closely against short-term requirements.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Quick Ratio

UnitedHealth Group Inc., quick ratio calculation (quarterly data)

Microsoft Excel
Sep 30, 2026 Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Cash and cash equivalents 25,845 28,585 28,001 24,365 27,210 28,596 30,717 25,312 32,400 26,286 28,414 25,427 38,915 41,813 41,913 23,365 38,845 24,612 25,482
Short-term investments 2,704 2,883 3,228 3,756 3,404 3,424 3,574 3,801 4,734 5,037 4,296 4,201 5,182 4,466 4,584 4,546 3,682 3,352 2,914
Accounts receivable, net 20,543 21,573 26,587 23,018 22,672 24,142 26,936 22,365 20,024 23,115 27,197 21,276 20,673 17,952 22,414 17,681 17,047 18,718 18,871
Other current receivables, net 27,577 24,722 24,588 29,697 32,762 28,582 26,022 26,089 27,461 26,762 19,284 17,694 17,752 16,131 14,696 12,769 13,684 12,439 11,994
Assets under management — — — — — — — — — 3,414 3,619 3,755 3,616 3,623 3,837 4,087 4,022 4,017 4,155
Total quick assets 76,669 77,763 82,404 80,836 86,048 84,744 87,249 77,567 84,619 84,614 82,810 72,353 86,138 83,985 87,444 62,448 77,280 63,138 63,416
 
Current liabilities 115,835 111,820 114,124 114,897 115,526 110,781 113,471 103,769 101,565 104,670 104,431 99,054 114,179 112,981 116,482 89,237 100,935 88,698 88,170
Liquidity Ratio
Quick ratio1 0.66 0.70 0.72 0.70 0.74 0.76 0.77 0.75 0.83 0.81 0.79 0.73 0.75 0.74 0.75 0.70 0.77 0.71 0.72
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories 0.83 0.80 0.84 1.02 1.09 1.14 1.09 1.05 1.00 1.02 0.95 1.00 1.04 1.00 1.07 1.06 1.22 1.33 1.21
Elevance Health Inc. 1.34 1.38 1.32 1.41 1.43 1.32 1.31 1.32 1.34 1.32 1.23 1.30 1.29 1.32 1.31 1.27 1.21 1.22 1.23
Intuitive Surgical Inc. 2.28 3.58 3.20 3.72 3.42 3.90 3.73 3.00 3.21 3.94 4.31 3.83 4.44 4.36 4.30 3.56 4.19 4.49 4.40
Medtronic PLC 1.55 1.48 1.25 1.20 1.19 1.17 1.35 1.31 1.46 1.42 1.51 1.54 1.18 1.18 1.01 1.30 1.87 2.07 2.06

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q3 2026 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 76,669 ÷ 115,835 = 0.66

2 Click competitor name to see calculations.


The liquidity position over the analyzed period demonstrates a consistent trend where quick assets remain below the value of current liabilities, resulting in a quick ratio that stays below 1.0. While the ratio experienced a period of gradual improvement and peaked in 2024, a subsequent decline is observed through 2026.

Quick Ratio Trends
The quick ratio exhibited moderate stability between 0.70 and 0.77 throughout 2022 and 2023. A period of strengthening occurred in the first three quarters of 2024, reaching a peak of 0.83 by September 30, 2024. However, a steady downward trajectory followed, with the ratio falling to 0.66 by September 30, 2026, marking the lowest point in the analyzed timeframe.
Quick Assets Performance
Total quick assets showed significant volatility, fluctuating between a low of 62,448 million US dollars in December 2022 and a high of 87,444 million US dollars in March 2023. Assets generally remained within the 76,000 to 87,000 million US dollar range from 2023 through 2026, though a slight contraction is evident in the final quarters of 2026.
Current Liabilities Growth
Current liabilities demonstrated a general upward trend over the period. Starting at 88,170 million US dollars in March 2022, liabilities increased to a range between 110,000 and 116,000 million US dollars by 2025 and 2026. The growth in obligations has outpaced the growth of quick assets in the latter part of the period, contributing to the compression of the quick ratio.
Liquidity Implications
The sustained quick ratio below 1.0 indicates that the organization does not maintain sufficient highly liquid assets to cover all short-term obligations immediately. The decline toward 0.66 in late 2026 suggests an increasing reliance on other current assets or operational cash flow to meet current liabilities.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Cash Ratio

UnitedHealth Group Inc., cash ratio calculation (quarterly data)

Microsoft Excel
Sep 30, 2026 Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Cash and cash equivalents 25,845 28,585 28,001 24,365 27,210 28,596 30,717 25,312 32,400 26,286 28,414 25,427 38,915 41,813 41,913 23,365 38,845 24,612 25,482
Short-term investments 2,704 2,883 3,228 3,756 3,404 3,424 3,574 3,801 4,734 5,037 4,296 4,201 5,182 4,466 4,584 4,546 3,682 3,352 2,914
Assets under management — — — — — — — — — 3,414 3,619 3,755 3,616 3,623 3,837 4,087 4,022 4,017 4,155
Total cash assets 28,549 31,468 31,229 28,121 30,614 32,020 34,291 29,113 37,134 34,737 36,329 33,383 47,713 49,902 50,334 31,998 46,549 31,981 32,551
 
Current liabilities 115,835 111,820 114,124 114,897 115,526 110,781 113,471 103,769 101,565 104,670 104,431 99,054 114,179 112,981 116,482 89,237 100,935 88,698 88,170
Liquidity Ratio
Cash ratio1 0.25 0.28 0.27 0.24 0.26 0.29 0.30 0.28 0.37 0.33 0.35 0.34 0.42 0.44 0.43 0.36 0.46 0.36 0.37
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories 0.27 0.31 0.40 0.54 0.53 0.54 0.53 0.56 0.52 0.52 0.47 0.53 0.54 0.57 0.66 0.66 0.74 0.75 0.65
Elevance Health Inc. 0.81 0.85 0.82 0.88 0.89 0.79 0.79 0.85 0.90 0.86 0.82 0.87 0.90 0.92 0.91 0.86 0.87 0.86 0.86
Intuitive Surgical Inc. 1.60 2.71 2.36 2.96 2.72 3.15 2.93 2.30 2.52 3.20 3.49 3.15 3.86 3.77 3.59 2.90 3.50 3.78 3.58
Medtronic PLC 0.88 0.84 0.70 0.70 0.67 0.66 0.76 0.74 0.85 0.80 0.87 0.88 0.77 0.79 0.63 0.85 1.26 1.37 1.36

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q3 2026 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 28,549 ÷ 115,835 = 0.25

2 Click competitor name to see calculations.


An analysis of the liquidity position from March 31, 2022, through September 30, 2026, reveals a general contraction in the immediate liquidity buffer. The most significant trend is a long-term decline in the cash ratio, which indicates a reduced capacity to cover current liabilities using only cash and cash equivalents.

Cash Asset Volatility
Total cash assets exhibited significant fluctuations throughout the period. A period of accumulation peaked in March 2023 at 50,334 million US dollars, following a previous surge in September 2022. However, a subsequent downward trend emerged, with cash assets declining to a low of 28,121 million US dollars by December 31, 2025. While some recovery occurred in early 2026, the cash levels remained substantially lower than the peaks observed in 2022 and 2023.
Current Liability Expansion
Current liabilities showed a general upward trajectory, increasing from 88,170 million US dollars in March 2022 to 115,835 million US dollars by September 30, 2026. Although there were intermittent decreases, such as the drop to 99,054 million US dollars in December 2023, the overall trend reflects a growing volume of short-term obligations over the analyzed timeframe.
Cash Ratio Deterioration
The cash ratio, driven by the combination of declining cash assets and rising current liabilities, demonstrates a clear downward trend. The ratio peaked at 0.46 in September 2022 but entered a period of steady erosion starting in 2024. The ratio fell below 0.30 in December 2024 and reached a minimum of 0.24 by December 31, 2025. By the end of the period in September 2026, the ratio stood at 0.25, representing a notable decrease from the 0.37 observed at the start of the sequence.

The convergence of increasing short-term liabilities and diminishing cash reserves has led to a weakened immediate liquidity profile. The transition from a peak ratio of 0.46 to a concluding ratio of 0.25 suggests a strategic shift in cash management or an increase in operational obligations that outpaces the growth of the most liquid assets.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?